Pitavastatin Drug Profile

What is Pitavastatin?

Pitavastatin is a prescription medication belonging to a class of drugs called HMG-CoA reductase inhibitors, commonly known as statins. It is primarily used to lower cholesterol levels in the blood and reduce the risk of cardiovascular disease. Pitavastatin works by blocking an enzyme in the liver responsible for cholesterol production.

Uses

Pitavastatin is approved for several cardiovascular conditions:

• Primary hypercholesterolemia: Treatment of elevated LDL cholesterol and total cholesterol levels in patients with high cholesterol
• Mixed dyslipidemia: Management of multiple lipid abnormalities, including high triglycerides and low HDL cholesterol
• Cardiovascular risk reduction: Prevention of heart attacks and strokes in patients with established cardiovascular disease
• Familial hypercholesterolemia: Treatment of inherited conditions causing extremely high cholesterol levels
• Atherosclerotic cardiovascular disease prevention: Reducing progression of plaque buildup in arteries

How it works

Pitavastatin blocks HMG-CoA reductase, an enzyme that controls the rate-limiting step in cholesterol synthesis in the liver. By inhibiting this enzyme, the medication reduces the liver’s ability to produce cholesterol, forcing cells to absorb more cholesterol from the bloodstream. This mechanism effectively lowers blood cholesterol levels and may also have anti-inflammatory effects that benefit cardiovascular health.

Side effects

Common side effects include:

Submit Your Paper

• Muscle pain or weakness (myalgia)
• Headache
• Back pain
• Constipation
• Diarrhea
• Fatigue
• Nausea
• Elevated liver enzymes

Serious side effects to watch for:

• Rhabdomyolysis (severe muscle breakdown)
• Severe liver damage or hepatitis
• New onset diabetes or worsening blood sugar control
• Memory problems or confusion
• Severe allergic reactions

Warnings and precautions

• Pregnancy and breastfeeding: Contraindicated in pregnancy and breastfeeding as it may harm fetal development and is excreted in breast milk
• Liver disease: Should not be used in patients with active liver disease or unexplained persistent elevations in liver enzymes
• Kidney impairment: Dose adjustment may be necessary in patients with severe kidney disease
• Muscle disorders: Patients with a history of muscle problems or taking certain medications may have increased risk of muscle-related side effects
• Age considerations: Elderly patients may be more susceptible to side effects and may require lower starting doses

Interactions

• Cyclosporine: Significantly increases pitavastatin levels, requiring dose reduction or alternative therapy
• Gemfibrozil: Increases risk of muscle toxicity when combined with statins
• Warfarin: May enhance anticoagulant effects, requiring more frequent monitoring
• Erythromycin and clarithromycin: These antibiotics can increase statin levels and toxicity risk
• Niacin (high doses): Combined use may increase risk of muscle problems
• Rifampin: May reduce pitavastatin effectiveness by increasing its metabolism
• Colchicine: Combination may increase risk of muscle toxicity
• Red yeast rice supplements: Contains natural statins and may increase risk of side effects

Check interactions with the GMJ Interaction Checker

Dosage

The typical starting dose for adults is 2 mg once daily, which can be taken with or without food. The dose may be adjusted based on individual response and cholesterol targets, with a maximum recommended dose of 4 mg daily. Some patients may start with 1 mg daily if they are at higher risk for side effects. Dosage adjustments are recommended for patients with kidney impairment, and lower starting doses may be appropriate for elderly patients or those taking interacting medications. All dosage decisions should be made by a healthcare provider based on individual patient factors, cholesterol levels, and cardiovascular risk assessment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).